Home > Product > Pramipexole SR
| CATEGORY |
PRODUCT PROFILE |
| PRODUCT NAME |
Pramipexole SR (Sustained Release) Tablet
(Original : Mirapex SR Tablet from Boehringer-Ingelheim)
|
| COMPANY |
Biopharmartis |
DEVELOPMENT
STATUS |
Launched in Korea in March, 2014 with the brand name of Mirap SR
(All three strengths : 0.375mg, 0.75mg & 1.5mg)
|
| THERAPEUTIC AREA |
Parkinson’s Disease |
| ACTION |
Dopamine D3 receptor agonist |
| STRENGTH |
- Diffusion Matrix type SR formulation with identical multi-strength release profile
- Tablet formulation patent with non-infringement of original formulation patent
- PCT available (PCT/KR2011/003515)
- Identical mechanism in simulated gastric fluid compared with original product (Consider BE test in fed / fasted mode)
- Simplified manufacturing process = Low manufacturing cost
|
| TECHNOLOGY |
SR Platform |
